Donor-derived Cell-free DNA Evaluation in Pediatric Heart Transplant Recipients: A Single-center 12-mo Experience
Collectively, results indicate that dd-cfDNA monitoring has a high negative prognostic value, suggesting that in heart transplanted children with dd-cfDNA levels of <0.55% threshold, protocol EMBs may be postponed.
Authors
- Carlo Pace Napoleone (ORCID: https://orcid.org/0000-0001-7039-5309)
- Gabriele Togliatto (ORCID: https://orcid.org/0000-0002-3123-7823)
- Tiziana Vaisitti (ORCID: https://orcid.org/0000-0002-3375-6985)
- Paola Burlo
- Antonio Amoroso (ORCID: https://orcid.org/0000-0002-9437-9407)
- Cristiana Caorsi
- Silvia Deaglio (ORCID: https://orcid.org/0000-0003-0632-5036)
- Monica Sorbini (ORCID: https://orcid.org/0009-0008-3308-7647)
- Enrico Aidala
- Francesco Edoardo Vallone (ORCID: https://orcid.org/0009-0006-0824-1038)
- Morteza Mansouri
- Tullia Carradori
Institutions
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Ospedale Regina Margherita (IT)
- University of Turin (IT)
Publication Details
- Journal
- Transplantation Direct
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1097/txd.0000000000001689
- Citations
- 3
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.72